Regency Fincorp Limited announced that it expects to receive INR 131.067 million in funding from Max Bio Biosciences Private Limited, Resimpex Real Estate Private Limited, Regency Digitrade Investments Private Limited and another investor

REGENCY FINCORP LIMITED announced a private placement to issue Unsecured/Secured Listed/Unlisted Non-Convertible Debentures and ) Issuance of 6,553,350 common shares at an issue price of INR 20 per share for the gross proceeds of INR 131,067,000 on May 3, 2024. The transaction will include participation from new and returning investors Max-Bio Biosciences Private Limited for 750,000 shares, Resimpex Real Estate Private Limited for 3,570,000 shares, Regency Digitrade Investments Private Limited for 233,350 shares and Neha Abrol for 2,000,000 shares. The transaction has been approved by the shareholders of the company and is subject to Annual General Meeting scheduled to be held on June 4, 2024.

The transaction of Unsecured/Secured Listed/Unlisted Non-Convertible Debentures subject to the approval of Members at the ensuing Annual General Meeting of the Company subject to the approval of shareholders in the ensuing General Meeting of the company.